About REENGAGE THERAPEUTICS INC.
ReEngage Therapeutics is a biopharmaceutical R&D company focused on developing drugs that treat longevity-related diseases by modifying epigenetic targets implicated in aging-related disorders, including neurodegeneration and cancer.
Development of drugs targeting epigenetic mechanisms in aging-related diseasesExclusive licensing of ACSS2 inhibitors for cancer from Epivario Inc.Sponsored research agreements with MD Anderson Cancer CenterCollaboration with Scripps Florida's high throughput screening team
Is this your company?
Claim REENGAGE THERAPEUTICS INC. to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim REENGAGE THERAPEUTICS INC. & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.